3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Uveal Melanoma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Lung Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Adenoma, Islet Cell
1
Interventions
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
cabozantinib
2
aldesleukin
2
Specimen Handling
2
CTLA-4 Antigen
2
Adoptive Transfer
2
niraparib
1
lenvatinib
1
entinostat
1
enfortumab vedotin
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
avelumab
1
Psychiatric Nursing
1
Platinum
1
Physical Therapy Modalities
1
Palliative Care
1
Paclitaxel
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Cisplatin
1
CP protocol
1
Biopsy
1
BAY 1895344
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Penile Neoplasms
×
aflibercept
×
1 year
×
Clear all
No trials found.